Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Expansion Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04678648
What this trial is testing

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more
RasCal Therapeutics, Inc. 134
Early research (Phase 1)Study completedNCT03270176
What this trial is testing

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasms
Debiopharm International SA 54
Early research (Phase 1)Study completedNCT02789345
What this trial is testing

Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Not applicableNot Yet RecruitingNCT07822139
What this trial is testing

Acute and Long-Term Effects of Integrated Myofascial Release Therapy on Respiratory Function in Healthy Adults

Who this might be right for
Respiratory Function
Karabuk University 40
Early research (Phase 1)Ended earlyNCT05084859
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Who this might be right for
Castration-resistant Prostate CancerNon-small Cell Lung CancerColorectal Cancer
Biosplice Therapeutics, Inc. 30
Not applicableStudy completedNCT00245427
What this trial is testing

Outcomes of Patients Not Responding to Antibiotics in the Community

Who this might be right for
SinusitisBronchitis, ChronicPneumonia, Bacterial
CPL Associates 200
Not applicableLooking for participantsNCT07451405
What this trial is testing

The Effect of Oscillation and Lung Expansion (OLE) Therapy in Prolonged Mechanical Ventilated Patients With Atelectasis Evaluated in Multiple Methods

Who this might be right for
Atelectasis
Capital Medical University 60
Not applicableLooking for participantsNCT03422302
What this trial is testing

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

Who this might be right for
Lung CarcinomaMalignant Respiratory Tract NeoplasmMetastatic Malignant Neoplasm in the Lung
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT05091528
What this trial is testing

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more
Silverback Therapeutics 2
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Not applicableStudy completedNCT03083379
What this trial is testing

Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy

Who this might be right for
VentilationBreathingAtelectasis
University of Virginia 30
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Early research (Phase 1)Ended earlyNCT06580938
What this trial is testing

Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Who this might be right for
Non Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more
Pfizer 4
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Not applicableUnknownNCT06041295
What this trial is testing

Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery

Who this might be right for
Lung Expansion TherapyPost-cardiac Surgery
National Taiwan University Hospital 60
Not applicableUnknownNCT04582214
What this trial is testing

Oscillation and Lung Expansion Therapy in Patients With COVID-19

Who this might be right for
COVID-19Oscillation and Lung Expansion
Hill-Rom 6
Early research (Phase 1)Study completedNCT02411591
What this trial is testing

Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Eli Lilly and Company 66
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Next Page